Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

FLAC

Frazier LifeSciences Acq... (FLAC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FLAC
DataOraFonteTitoloSimboloCompagnia
15/02/202316:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
02/12/202222:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/11/202219:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202222:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202214:00GlobeNewswire Inc.NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular DiseaseNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
22/11/202222:17Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
15/11/202217:31Business WireFrazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
15/11/202200:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/11/202222:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
13/10/202223:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
26/09/202214:00GlobeNewswire Inc.Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of DirectorsNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/07/202214:00Business WireNewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic DiseasesNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/03/202222:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
14/02/202223:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
31/01/202222:44Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
31/01/202222:41Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
17/05/202122:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FLAC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network